Method for administering high-dose inhalants

Knowledge Center

Patent / Jan 01, 2013

Method for administering high-dose inhalants

Authors:

Pedro Mendes
Phillip Nelson
Ana Goncalves

Source:

WO 2013104892

A method is disclosed for administration of high-dose inhalants contg. mucolytics, buffers, and other agents and excipients. The formulations of invention may be used in treatment, e.g., of COPD.

Also in the Knowledge Center

/ Jan 01, 2012

A hybrid approach to reach stringent low genotoxic impurity contents in active pharmaceutical ingredients: Combining molecularly imprinted polymers and organic solvent nanofiltration for removal of 1,3-diisopropylurea

Scientific Article

View

/ Jan 01, 1998

Pharmacokinetics, protein binding, and metabolic profile of 3H-icometasone enbutate following intravenous, oral, and intratracheal administrations to Sprague-Dawley rats

Scientific Article

View

��ɫAV

Browser not supported

Knowledge Center

Method for administering high-dose inhalants

Also in the Knowledge Center

A hybrid approach to reach stringent low genotoxic impurity contents in active pharmaceutical ingredients: Combining molecularly imprinted polymers and organic solvent nanofiltration for removal of 1,3-diisopropylurea

Pharmacokinetics, protein binding, and metabolic profile of 3H-icometasone enbutate following intravenous, oral, and intratracheal administrations to Sprague-Dawley rats

��ɫAV

Browser not supported

Knowledge Center

Method for administering high-dose inhalants

Also in the Knowledge Center

A hybrid approach to reach stringent low genotoxic impurity contents in active pharmaceutical ingredients: Combining molecularly imprinted polymers and organic solvent nanofiltration for removal of 1,3-diisopropylurea

Pharmacokinetics, protein binding, and metabolic profile of 3H-icometasone enbutate following intravenous, oral, and intratracheal administrations to Sprague-Dawley rats

Related Content

Exclusive partnerships

Papillon DPI

OWN it! Training and Development Needs FY24